Inhibition of human B cell responsiveness by prostaglandin E2

N. J. Simkin, Diane F Jelinek, P. E. Lipsky

Research output: Contribution to journalArticle

93 Citations (Scopus)

Abstract

The capacity of prostaglandin E2 (PGE2) to modulate human peripheral blood B cell proliferation and the generation of immunoglobulin-secreting cells (ISC) stimulated by Cowan 1 strain Staphylococcus aureus and mitogen-stimulated T cell supernatant was examined. PGE2 significantly inhibited both responses, whereas PGF(2α) had no inhibitory effect. Responses of highly purified B cells obtained from spleen, lymph node, and tonsil were also inhibited. In addition PGE2 suppressed B cell responses supported by recombinant interleukin 2 rather than T cell supernatant. PGE2-mediated inhibition was mimicked by forskolin, a direct activator of adenylate cyclase. Kinetic studies indicated that PGE2 inhibited B cell responses by a progressively greater increment as cultures were prolonged. Evaluation by flow cytometry after staining with acridine orange or mithramycin indicated that PGE2 had no effect on initial B cell entry into the G1 phase of the cell cycle, passage through G1, and entry into S, G2, and M. Rather, PGE2 inhibited responses of postdivisional daughter cells. PGE2 inhibited responses in cultures stimulated by the calcium ionophore ionomycin and T cell supernatant but had minimal effects in cultures stimulated by the combination of ionomycin and phorbol myristate acetate. Moreover, phorbol myristate acetate reversed PGE2-mediated inhibition of proliferation stimulated by S. aureus or S. aureus + T cell supernatant. These results indicate that PGE2 suppresses the continued growth and differentiation of human B cells, although it has no effect on initial B cell activation and suggest that PGE2 may play a role in regulating human B cell responses in vivo.

Original languageEnglish (US)
Pages (from-to)1074-1081
Number of pages8
JournalJournal of Immunology
Volume138
Issue number4
StatePublished - 1987
Externally publishedYes

Fingerprint

Dinoprostone
B-Lymphocytes
T-Lymphocytes
Staphylococcus aureus
Ionomycin
Tetradecanoylphorbol Acetate
Plicamycin
Antibody-Producing Cells
Acridine Orange
Calcium Ionophores
Palatine Tonsil
G1 Phase
Prostaglandins F
Colforsin
Mitogens
Adenylyl Cyclases
Interleukin-2
Blood Cells
Cell Cycle
Flow Cytometry

ASJC Scopus subject areas

  • Immunology

Cite this

Inhibition of human B cell responsiveness by prostaglandin E2 . / Simkin, N. J.; Jelinek, Diane F; Lipsky, P. E.

In: Journal of Immunology, Vol. 138, No. 4, 1987, p. 1074-1081.

Research output: Contribution to journalArticle

Simkin, NJ, Jelinek, DF & Lipsky, PE 1987, 'Inhibition of human B cell responsiveness by prostaglandin E2 ', Journal of Immunology, vol. 138, no. 4, pp. 1074-1081.
Simkin, N. J. ; Jelinek, Diane F ; Lipsky, P. E. / Inhibition of human B cell responsiveness by prostaglandin E2 In: Journal of Immunology. 1987 ; Vol. 138, No. 4. pp. 1074-1081.
@article{e9fdfab0a50f43328cff18c524f64981,
title = "Inhibition of human B cell responsiveness by prostaglandin E2",
abstract = "The capacity of prostaglandin E2 (PGE2) to modulate human peripheral blood B cell proliferation and the generation of immunoglobulin-secreting cells (ISC) stimulated by Cowan 1 strain Staphylococcus aureus and mitogen-stimulated T cell supernatant was examined. PGE2 significantly inhibited both responses, whereas PGF(2α) had no inhibitory effect. Responses of highly purified B cells obtained from spleen, lymph node, and tonsil were also inhibited. In addition PGE2 suppressed B cell responses supported by recombinant interleukin 2 rather than T cell supernatant. PGE2-mediated inhibition was mimicked by forskolin, a direct activator of adenylate cyclase. Kinetic studies indicated that PGE2 inhibited B cell responses by a progressively greater increment as cultures were prolonged. Evaluation by flow cytometry after staining with acridine orange or mithramycin indicated that PGE2 had no effect on initial B cell entry into the G1 phase of the cell cycle, passage through G1, and entry into S, G2, and M. Rather, PGE2 inhibited responses of postdivisional daughter cells. PGE2 inhibited responses in cultures stimulated by the calcium ionophore ionomycin and T cell supernatant but had minimal effects in cultures stimulated by the combination of ionomycin and phorbol myristate acetate. Moreover, phorbol myristate acetate reversed PGE2-mediated inhibition of proliferation stimulated by S. aureus or S. aureus + T cell supernatant. These results indicate that PGE2 suppresses the continued growth and differentiation of human B cells, although it has no effect on initial B cell activation and suggest that PGE2 may play a role in regulating human B cell responses in vivo.",
author = "Simkin, {N. J.} and Jelinek, {Diane F} and Lipsky, {P. E.}",
year = "1987",
language = "English (US)",
volume = "138",
pages = "1074--1081",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "4",

}

TY - JOUR

T1 - Inhibition of human B cell responsiveness by prostaglandin E2

AU - Simkin, N. J.

AU - Jelinek, Diane F

AU - Lipsky, P. E.

PY - 1987

Y1 - 1987

N2 - The capacity of prostaglandin E2 (PGE2) to modulate human peripheral blood B cell proliferation and the generation of immunoglobulin-secreting cells (ISC) stimulated by Cowan 1 strain Staphylococcus aureus and mitogen-stimulated T cell supernatant was examined. PGE2 significantly inhibited both responses, whereas PGF(2α) had no inhibitory effect. Responses of highly purified B cells obtained from spleen, lymph node, and tonsil were also inhibited. In addition PGE2 suppressed B cell responses supported by recombinant interleukin 2 rather than T cell supernatant. PGE2-mediated inhibition was mimicked by forskolin, a direct activator of adenylate cyclase. Kinetic studies indicated that PGE2 inhibited B cell responses by a progressively greater increment as cultures were prolonged. Evaluation by flow cytometry after staining with acridine orange or mithramycin indicated that PGE2 had no effect on initial B cell entry into the G1 phase of the cell cycle, passage through G1, and entry into S, G2, and M. Rather, PGE2 inhibited responses of postdivisional daughter cells. PGE2 inhibited responses in cultures stimulated by the calcium ionophore ionomycin and T cell supernatant but had minimal effects in cultures stimulated by the combination of ionomycin and phorbol myristate acetate. Moreover, phorbol myristate acetate reversed PGE2-mediated inhibition of proliferation stimulated by S. aureus or S. aureus + T cell supernatant. These results indicate that PGE2 suppresses the continued growth and differentiation of human B cells, although it has no effect on initial B cell activation and suggest that PGE2 may play a role in regulating human B cell responses in vivo.

AB - The capacity of prostaglandin E2 (PGE2) to modulate human peripheral blood B cell proliferation and the generation of immunoglobulin-secreting cells (ISC) stimulated by Cowan 1 strain Staphylococcus aureus and mitogen-stimulated T cell supernatant was examined. PGE2 significantly inhibited both responses, whereas PGF(2α) had no inhibitory effect. Responses of highly purified B cells obtained from spleen, lymph node, and tonsil were also inhibited. In addition PGE2 suppressed B cell responses supported by recombinant interleukin 2 rather than T cell supernatant. PGE2-mediated inhibition was mimicked by forskolin, a direct activator of adenylate cyclase. Kinetic studies indicated that PGE2 inhibited B cell responses by a progressively greater increment as cultures were prolonged. Evaluation by flow cytometry after staining with acridine orange or mithramycin indicated that PGE2 had no effect on initial B cell entry into the G1 phase of the cell cycle, passage through G1, and entry into S, G2, and M. Rather, PGE2 inhibited responses of postdivisional daughter cells. PGE2 inhibited responses in cultures stimulated by the calcium ionophore ionomycin and T cell supernatant but had minimal effects in cultures stimulated by the combination of ionomycin and phorbol myristate acetate. Moreover, phorbol myristate acetate reversed PGE2-mediated inhibition of proliferation stimulated by S. aureus or S. aureus + T cell supernatant. These results indicate that PGE2 suppresses the continued growth and differentiation of human B cells, although it has no effect on initial B cell activation and suggest that PGE2 may play a role in regulating human B cell responses in vivo.

UR - http://www.scopus.com/inward/record.url?scp=0023127297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023127297&partnerID=8YFLogxK

M3 - Article

VL - 138

SP - 1074

EP - 1081

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 4

ER -